Successful salvage therapy using high-dose furmonertinib (AST2818) for non–small-cell lung cancer after Osimertinib resistance: a case report.

Details

Language :

English

ISSN :

09594973

Volume :

33

Issue :

8

Database :

Complementary Index

Journal :

Anti-Cancer Drugs

Publication Type :

Academic Journal

Accession number :

158562519

Full Text :

https://doi.org/10.1097/CAD.0000000000001368